Literature DB >> 7925022

Cis-acting regulatory sequences governing Wnt-1 expression in the developing mouse CNS.

Y Echelard1, G Vassileva, A P McMahon.   

Abstract

The protooncogene Wnt-1 encodes a short-range signal which is first expressed in, and appears to demarcate, the presumptive midbrain. Absence of Wnt-1 expression leads to the loss of this region of the brain. By the end of neural tube closure, expression of Wnt-1 extends down much of the dorsal midline of the central nervous system (CNS). Expression is exclusively limited to the CNS at this and later stages. We have investigated the regulation of Wnt-1 during mouse development. Analysis of the embryonic expression of Wnt-1-lacZ reporter constructs spanning nearly 30 kb of the Wnt-1 locus identified a 5.5 kb cis-acting 3' enhancer element which confers correct temporal and spatial expression on the lacZ gene. Interestingly embryos express Wnt-1-lacZ transgenes in migrating neural crest cells which are derived from the dorsal CNS. Ectopic expression of the Wnt-1-lacZ transgenes may result from perdurance of beta-galactosidase activity in migrating neural crest cells originating from a Wnt-1-expressing region of the dorsal CNS. Alternatively, ectopic expression may arise from transient de novo activation of the transgenes in this cell population. These results are a first step towards addressing how regional cell signaling is established in the mammalian CNS. In addition, transgene expression provides a new tool for the analysis of neural crest development in normal and mutant mouse embryos.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925022     DOI: 10.1242/dev.120.8.2213

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  105 in total

1.  Asymmetric and node-specific nodal expression patterns are controlled by two distinct cis-acting regulatory elements.

Authors:  D P Norris; E J Robertson
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Analysis of 148 kb of genomic DNA around the wnt1 locus of Fugu rubripes.

Authors:  K Gellner; S Brenner
Journal:  Genome Res       Date:  1999-03       Impact factor: 9.043

3.  Dual embryonic origin of the mammalian otic vesicle forming the inner ear.

Authors:  Laina Freyer; Vimla Aggarwal; Bernice E Morrow
Journal:  Development       Date:  2011-12       Impact factor: 6.868

4.  Primary culture of chick, mouse or human neural crest cells.

Authors:  Heather Etchevers
Journal:  Nat Protoc       Date:  2011-09-22       Impact factor: 13.491

Review 5.  Neural crest and olfactory system: new prospective.

Authors:  Paolo E Forni; Susan Wray
Journal:  Mol Neurobiol       Date:  2012-07-08       Impact factor: 5.590

6.  cKit+ cardiac progenitors of neural crest origin.

Authors:  Konstantinos E Hatzistergos; Lauro M Takeuchi; Dieter Saur; Barbara Seidler; Susan M Dymecki; Jia Jia Mai; Ian A White; Wayne Balkan; Rosemeire M Kanashiro-Takeuchi; Andrew V Schally; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

7.  Cre recombinase-regulated Endothelin1 transgenic mouse lines: novel tools for analysis of embryonic and adult disorders.

Authors:  Andre L P Tavares; David E Clouthier
Journal:  Dev Biol       Date:  2015-02-25       Impact factor: 3.582

Review 8.  Molecular neuroanatomy's "Three Gs": a primer.

Authors:  Susan M Dymecki; Jun Chul Kim
Journal:  Neuron       Date:  2007-04-05       Impact factor: 17.173

9.  Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice.

Authors:  S M Dymecki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

10.  Comparative gene expression analysis of avian embryonic facial structures reveals new candidates for human craniofacial disorders.

Authors:  S A Brugmann; K E Powder; N M Young; L H Goodnough; S M Hahn; A W James; J A Helms; M Lovett
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.